Suppr超能文献

在移植了亲代骨髓和脾脏的辐照杂交小鼠造血组织中的竞争性增殖。

Competitive proliferation in the hematopoietic tissues of irradiated hybrid mice engrafted with parental bone marrow and spleen.

作者信息

Muramatsu S, Monnot P, Duplan J F

出版信息

Exp Hematol. 1976 Jul;4(4):188-200.

PMID:782893
Abstract

The kinetics of growth and differentiation of hematopoietic stem cells differ markedly according to their origin. A study of the ability of CFU from bone marrow (BM) or spleen to repopulate hemopoietic organs has been carried out in lethally irradiated mice restored with BM cells admixed with spleen cells bearing different chromosomal markers. Hemopoietic cells originating from AKR (40 acrocentrics) and AKR/T1ALD (36 acrocentrics + 2 metacentrics) mice were engrafted into lethally irradiated (AKR X AKR/T1ALD)F1 or (C3H X AKR/T1ALD)F1 hybrid recipients. Within 10 days, the BM-derived elements outnumbered the spleen-derived population in BM and spleen. This held even when the number of injected spleen-CFU was twice that of BM-CFU. This difference of growth rate subsided within 20 days. The first cells to reappear in the thymus bore the recipient karyotype (endoregeneration); they were later replaced by BM-derived elements but spleen-derived cells were never present in thymus in the case of competitive engraftment. In contrast, the lymph node cells bore the BM karyotype as well as the spleen karyotype. Injecting the spleen cells 3 days prior to the BM cells partially counterbalanced the over-growth of the BM-derived elements in the BM and spleen but did not affect the thymic repopulation which remained strictly derived from BM-CFU. When mice were injected only with BM-CFU or only with spleen-CFU, BM-derived cells were found in the thymus as early as 10-12 days after engraftment whereas the spleen-derived cells did not appear in the thymus until days 18-20.

摘要

造血干细胞的生长和分化动力学因其来源不同而有显著差异。在接受致死性照射并用含有不同染色体标记的脾细胞混合的骨髓细胞进行恢复的小鼠中,开展了一项关于来自骨髓(BM)或脾脏的集落形成单位(CFU)重新填充造血器官能力的研究。将源自AKR(40条近端着丝粒染色体)和AKR/T1ALD(36条近端着丝粒染色体 + 2条中着丝粒染色体)小鼠的造血细胞移植到接受致死性照射的(AKR×AKR/T1ALD)F1或(C3H×AKR/T1ALD)F1杂交受体中。10天内,骨髓和脾脏中源自骨髓的成分数量超过了源自脾脏的群体。即使注射的脾脏CFU数量是骨髓CFU数量的两倍,情况依然如此。这种生长速率的差异在20天内逐渐消失。最早出现在胸腺中的细胞具有受体核型(内再生);它们随后被源自骨髓的成分所取代,但在竞争性移植的情况下,胸腺中从未出现过源自脾脏的细胞。相比之下,淋巴结细胞同时具有骨髓核型和脾脏核型。在注射骨髓细胞前3天注射脾脏细胞,可部分抵消骨髓来源成分在骨髓和脾脏中的过度生长,但不影响胸腺的重新填充,胸腺的重新填充严格源自骨髓CFU。当仅给小鼠注射骨髓CFU或仅注射脾脏CFU时,移植后10 - 12天在胸腺中就发现了源自骨髓的细胞,而源自脾脏的细胞直到第18 - 20天才出现在胸腺中。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验